We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · May 01, 2017

Everolimus Plus Exemestane in Advanced Breast Cancer

The Oncologist


Additional Info

Disclosure statements are available on the authors' profiles:

The Oncologist
Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting
Oncologist 2017 Apr 21;[EPub Ahead of Print], D Generali, F Montemurro, R Bordonaro, A Mafodda, S Romito, A Michelotti, P Piovano, MT Ionta, C Bighin, D Sartori, A Frassoldati, ME Cazzaniga, F Riccardi, F Testore, P Vici, CA Barone, A Schirone, F Piacentini, F Nolè, A Molino, L Latini, EL Simoncini, F Roila, F Cognetti, F Nuzzo, J Foglietta, AM Minisini, F Goffredo, G Portera, G Ascione, G Mariani

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading